Bosulif® (Bosutinib)

Bosulif® (Bosutinib)

BOSULIF is a prescription medicine developed by Pfizer used to treat adults who have a certain type of leukemia called Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML) who are newly diagnosed or who no longer benefit from or did not tolerate other treatment. Learn more below.